“…The history of implantable CaPO 4 /polymer formulations started in 1981 (however, a more general topic “ceramic-plastic material as a bone substitute” is, at least, 18 years older [ 179 ]) from the pioneering study by Prof. William Bonfield and colleagues at Queen Mary College, University of London, performed on HA/PE blends [ 180 , 181 ]. That initial study introduced a bone-analogue concept, when proposed biocomposites comprised a polymer ductile matrix of PE and a ceramic stiff phase of HA, and was substantially extended and developed in further investigations by that research group [ 66 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 , 192 ]. More recent studies included investigations on the influence of surface topography of HA/PE composites on cell proliferation and attachment [ 193 , 194 , 195 , 196 ].…”